Improves cardiovascular function supplementation may improve lipid profile (lower LDL and TG, increase HDL), reduce homocysteine levels, and support heart muscle energy, especially in older adults
This study reported a similar incidence of MCMs following exposure to insulin (7.8%, n=5078) vs other antidiabetic agents: GLP-1 RAs (8.3% n=938), sodium-glucose co-transporter-2 inhibitors (SGLT2i) (7.0% n=335), sulfonylureas (9.7%, n=1362) and dipeptidyl peptidase 4 (DPP-4) inhibitors (6.1%, n=687)
28,38 One recent study suggested that age-associated microbiota dysbiosis played a significant role in the genesis of AF through a microbiota-gut-atria axis partly
European Neuropsychopharmacology, 23(10), 12191225
Glickman, MD, explains that success on a GLP-1 medication is considered a body weight loss of more than 5% after three months of treatment
IGF-1 LR3 This peptide supports muscle and bone repair by increasing protein synthesis and cellular growth